Frankenstein Proteins Stitched Together by Scientists

Biochemists implement computer-based protein design strategy inspired by evolution, confirm structural features in the laboratory

Enobia Chooses Lonza for Commercial-Scale Manufacture of Its Enzyme-Replacement Therapy

Contract covers the production of ENB-0040, which is being evaluated for treating hypophosphatasia.

Sartorius to Acquire TAP Biosystems

Deal, which values TAP Biosystems at around $44.8 million, would expand Sartorius' portfolio of single-use fermentors.

In Precambrian Park, Proteins Find a Way

Ancient proteins "resurrected" to provide clues that protein engineers could use to generate enzymes that contain new active sites and perform novel functions

Lonza Launches Fixed-Price Service for Preclinical Manufacturing

Proteins and plasmids reportedly can be generated in 10 to 15 weeks with guaranteed minimum quantities.

EMD Millipore, Centre for Commercialization of Regen Med to Optimize Large-Scale Stem Cell Cultivation

Monitoring and control methodology will be developed for EMD’s Mobius CellReady bioreactor.
Source: © vittavat - Fotolia.com

Roche Plans $467M Diagnostics Manufacturing Facility in China

The facility, to employ more than 600, will be Roche's eighth worldwide, and first in the fast-growing Asia-Pacific region

Seattle Genetics, Pieris Launch Up-to-$1.2B Immuno-Oncology Collaboration

The companies would work to create antibody–anticalin fusion proteins for solid tumors and blood cancers

FDA Gives Abbott a Thumbs-Up for Automated HBV Monitoring Test

Assay can be used with the Abbott m2000 system to understand response to treatment.

Novartis to Construct $500M Biologics Plant in Singapore

Novartis is to plough over $500 million into the construction of a new cell culture-based biomanufacturing plant in Singapore, sited alongside its existing pharmaceutical manufacturing facility at Tuas.

Recently Featured

Stay Connected

556,521FansLike
47,480FollowersFollow
Scroll Up